N-(pyrrolo(2,3-d)pyrimidin-3-ylacyl)-glutamic acid derivatives
US5344932A · kind A · utility
55Cited by
3References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 22, 1991 |
| Grant date | Sep 6, 1994 |
| Priority date | — |
| Expiry date | Mar 22, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
N-(Acyl)glutamic acid derivatives in which the acyl group is substituted with 4-hydroxypyrrolo[2,3-d]-pyrimidin-3-yl group are antineoplastic agents. A typical embodiment is N-[4-(2-{4-hydroxy-6-aminopyrrolo-[2,3-d]pyrimidin-3-yl}ethyl)benzoyl]-L-g lutamic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.